# ImageneBio (IMA) — Analyst Forecast

IMA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ima/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 3 | 0 | 1 | 4 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 21, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $28.00 |
| May 11, 2026 | Wedbush | Maintained | Underperform | $2.00 |
| Nov 25, 2025 | Wedbush | Initiated Coverage | Underperform | $2.00 |
| Oct 24, 2025 | Leerink Partners | Initiated Coverage | Outperform | $30.00 |
| Jul 25, 2025 | Wedbush | Maintained | Neutral | $23.00 |
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| May 29, 2024 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| May 29, 2024 | Wedbush | Downgraded | Outperform → Neutral | $2.00 |
| May 14, 2024 | Wedbush | Maintained | Outperform | $8.00 |
| Mar 19, 2024 | HC Wainwright & Co. | Maintained | Buy | $11.00 |
| Mar 12, 2024 | HC Wainwright & Co. | Maintained | Buy | $11.00 |
| Jan 19, 2024 | HC Wainwright & Co. | Maintained | Buy | $11.00 |
| Jan 19, 2024 | Wedbush | Maintained | Outperform | $8.00 |
| Nov 9, 2023 | HC Wainwright & Co. | Maintained | Buy | $11.00 |
| Sep 22, 2023 | Wedbush | Initiated Coverage | Outperform | $11.00 |
| Aug 10, 2023 | HC Wainwright & Co. | Maintained | Buy | $18.00 |
| Aug 7, 2023 | HC Wainwright & Co. | Maintained | Buy | $18.00 |
| May 24, 2023 | HC Wainwright & Co. | Maintained | Buy | $18.00 |
| May 16, 2023 | Credit Suisse | Maintained | Outperform | $13.00 |

## Frequently Asked Questions

### Is IMA a buy, sell, or hold?

Analysts covering ImageneBio currently average a Buy rating: 3 buy, 0 hold and 1 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on IMA?

On Aug 21, 2026, HC Wainwright & Co. initiated coverage of ImageneBio at Buy with a price target of $28.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).